Advertisement

Topics

EU expands label of Amgen's Repatha

06:04 EDT 17 May 2018 | SmartBrief

Amgen's Repatha, or evolocumab, was approved by the European Commission to reduce low-density lipoprotein levels in adult pat -More

Original Article: EU expands label of Amgen's Repatha

NEXT ARTICLE

More From BioPortfolio on "EU expands label of Amgen's Repatha"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...